Why hallucinations happen in Parkinson's and which treatments actually work

Catching a fleeting shadow out of the corner of your eye, or sensing someone standing in an empty room, is far more common in Parkinson's than most people talk about. Up to 60 per cent of people experience these sensory glitches, and a third notice them years before ever developing a tremor or stiffness. A coat hung on a door looks like a stranger, a patterned rug seems to crawl, or a phantom pet scampers past the skirting board. Early on, people know it is an optical trick. Over time, these fleeting moments can harden into vivid figures, imaginary sounds, or unshakeable suspicions. This is not madness, and it is not simply too much levodopa. The condition itself rewires how the brain handles sight. When damaged visual circuits cannot process incoming light clearly, the brain guesses the rest, pulling random memories from storage to fill the dark spots. Disrupted serotonin, depleted acetylcholine, and chaotic REM sleep only blur the line between dreams and reality further. Before reaching for new prescriptions, the first step is hunting down mundane culprits. A silent urinary tract infection, mild dehydration, or three nights of broken sleep can unravel brain chemistry overnight. Clearing an infection or trimming non essential medications often stops the illusions cold. When drug treatment is unavoidable, modern medicine faces an embarrassing contradiction. Randomised clinical trials prove that only two drugs work without stiffening limbs: pimavanserin, which targets serotonin to spare movement, and clozapine, which requires relentless blood tests to monitor white blood cells. Because of those hurdles, doctors most often prescribe quetiapine. The inconvenient truth from clinical trials is that quetiapine performs no better than a sugar pill, while older sedatives freeze motor function entirely. Knowing the real biology helps spot the signs early, avoid ineffective drugs, and protect clear headed independence.